Introduction to Reduces Plasma
Sentence Examples
Discover more insights into Reduces Plasma
Keywords frequently search together with Reduces Plasma
Narrow sentence examples with built-in keyword filters
Reduces Plasma sentence examples within Significantly Reduces Plasma
Context Faecal microbiota transplantation (FMT) from Kazak individuals with normal glucose tolerance (KNGT) significantly reduces plasma glycolipid levels in type 2 diabetes mellitus db/db mice.
Full Text
Animal studies indicate that the use of ANGPTL3 (evinacumab) inhibitors significantly reduces plasma total cholesterol, triglycerides and low-density lipoprotein concentrations.
Full Text
Reduces Plasma sentence examples within Also Reduces Plasma
Of note, aHepGHRkd also reduces plasma IGF1 levels to >80% of GHR-intact controls (GHRfl/fl mice treated with AAV8-TBGp-Null), leading to a rise in GH, due to loss of IGF1 negative feedback to the pituitary/hypothalamus.
Full Text
Pyritinol has also been shown to act as an antioxidant and anti-inflammatory agent, and also reduces plasma viscosity.
Full Text
Reduces Plasma sentence examples within Tea Reduces Plasma
These results suggest that black tea reduces plasma concentrations of rosuvastatin by inhibiting intestinal OATP2B1-mediated transport of rosuvastatin.
Full Text
Learn more from Reduces Plasma
Reduces Plasma sentence examples within Hypercholesteremium Reduces Plasma
Reduces Plasma sentence examples within reduces plasma triglyceride
BACKGROUND
Volanesorsen is an antisense oligonucleotide that targets hepatic apolipoprotein C-III synthesis and reduces plasma triglyceride concentration.
Full Text
CONCLUSION
SM administration reduces plasma triglyceride levels through attenuation of triglyceride intestinal absorption and modulates cardiac lipotoxicity in the ischemic myocardium, likely contributing to improve ventricular remodeling.
Full Text
Reduces Plasma sentence examples within reduces plasma lipid
Reduces Plasma sentence examples within reduces plasma concentration
Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition reduces plasma concentrations of low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (apoB) and lipoprotein(a) [Lp(a)].
Full Text
Recent studies suggest that liraglutide reduces plasma concentration of C-reative protein in patients with type 1 diabetes and protects β cell function in the non-obese diabetic mouse.
Full Text
Reduces Plasma sentence examples within reduces plasma glucose
CONCLUSIONS/INTERPRETATION
Low dose gliclazide reduces plasma glucose in response to oral glucose load, with concomitant augmentation of the classical incretin effect.
Full Text
Conclusions Artesunate reduces plasma glucose by reducing plasma glucagon concentrations and inhibiting liver glycogenolysis via inhibition of G6Pase activity in both sexes.
Full Text
Reduces Plasma sentence examples within reduces plasma cholesterol
Remarkably, GPR146 deficiency reduces plasma cholesterol levels substantially in both wild-type and LDL receptor (LDLR)-deficient mice.
Full Text
&NA; The therapy with proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors efficiently reduces plasma cholesterol levels, which has been recently associated with improvement in cardiovascular outcomes.
Full Text
Reduces Plasma sentence examples within reduces plasma insulin
We validated the effect of Agpat5, showing in multiple mouse models that treatment with Agpat5 antisense oligonucleotide (ASO) reduces plasma insulin after high-fat feeding.
Full Text
In addition, metformin reduces plasma insulin concentration in subjects with impaired glucose tolerance and diabetes and decreases the amount of insulin required for metabolic control in patients with diabetes, reflecting improvement of insulin activity.
Full Text
Reduces Plasma sentence examples within reduces plasma ca2
Short-term experimental hypermagnesemia alters calcium-regulating hormones (PTH, CT), reduces plasma Ca2+ concentrations, and increases the urinary excretion of Mg2+, Ca2+, K+, Na+ and Cl- in healthy horses.
Full Text
Experimental hypermagnesemia alters calcium-regulating hormones (PTH, CT), reduces plasma Ca2+ concentrations, and increases the urinary excretion of Mg2+, Ca2+, K+, Na+ and Cl- in healthy horses.
Full Text
Reduces Plasma sentence examples within reduces plasma total
Animal studies indicate that the use of ANGPTL3 (evinacumab) inhibitors significantly reduces plasma total cholesterol, triglycerides and low-density lipoprotein concentrations.
Full Text
CONCLUSIONS
Induced PLTP deficiency in adult mice reduces plasma total cholesterol and triglycerides, prevents atherosclerosis progression, and promotes atherosclerosis regression.
Full Text
Sodium acetate reduces plasma and renal surrogate oxidative stress markers, improved G6PD-dependent antioxidant index, and HOMA-IR in NP+F and P+F groups.
Full Text
The new plasma system allows an increase in the plasma-surface interaction selectivity and reduces plasma-induced damages to the surface.
Full Text
Short-term experimental hypermagnesemia alters calcium-regulating hormones (PTH, CT), reduces plasma Ca2+ concentrations, and increases the urinary excretion of Mg2+, Ca2+, K+, Na+ and Cl- in healthy horses.
Full Text
Its inhibition in people with hypercholesteremia reduces plasma lipid levels dramatically.
Full Text
CONCLUSIONS/INTERPRETATION
Low dose gliclazide reduces plasma glucose in response to oral glucose load, with concomitant augmentation of the classical incretin effect.
Full Text
Experimental hypermagnesemia alters calcium-regulating hormones (PTH, CT), reduces plasma Ca2+ concentrations, and increases the urinary excretion of Mg2+, Ca2+, K+, Na+ and Cl- in healthy horses.
Full Text
Context Faecal microbiota transplantation (FMT) from Kazak individuals with normal glucose tolerance (KNGT) significantly reduces plasma glycolipid levels in type 2 diabetes mellitus db/db mice.
Full Text
Conclusions Artesunate reduces plasma glucose by reducing plasma glucagon concentrations and inhibiting liver glycogenolysis via inhibition of G6Pase activity in both sexes.
Full Text
Its inhibition in people with hypercholesteremia reduces plasma lipid levels dramatically.
Full Text
The formation of anti-adalimumab antibodies (AAA) reduces plasma ADA serum concentrations (ADAsc), as well as its efficacy.
Full Text
CONCLUSION
Our study suggests ROTEM may be advantageous for evaluating coagulopathy in patients with liver disease and ROTEM-guided transfusion reduces plasma transfusion.
Full Text
Whereas CREB3L3 deficiency leads to massive accumulation of hepatic lipids and to an increase in plasma triglyceride (TG) levels, its overexpression reduces plasma TG levels by promoting the hepatic expression of regulators of arteriosclerosis, such as apolipoprotein A4 (Apoa4), Apoa5, and Apoc2.
Full Text
While DFPP reduces plasma product exposure, risk of circuit clotting merits adequate anticoagulation.
Full Text
CONCLUSION
A high prevalence of discordant LDL-C/Lp(a) response was observed with alirocumab, further suggesting that PCSK9 inhibitor therapy with alirocumab reduces plasma Lp(a) through alternative pathways to LDL receptor clearance.
Full Text
We propose that lack of albumin reduces plasma FFA which diminishes hepatic TAG content through changes in the lipid supply to the liver.
Full Text
Reported here is a fit-for-purpose LC/MS method that reduces plasma volume from 700 to 25 µL and omits pre-concentration steps.
Full Text
Animal studies indicate that the use of ANGPTL3 (evinacumab) inhibitors significantly reduces plasma total cholesterol, triglycerides and low-density lipoprotein concentrations.
Full Text
The aim of the study was to show that Nx4 reduces plasma cortisol and plasma gastrin in high performance sled dogs and to show tolerability of Nx4 in dogs.
Full Text
BACKGROUND
Volanesorsen is an antisense oligonucleotide that targets hepatic apolipoprotein C-III synthesis and reduces plasma triglyceride concentration.
Full Text
CONCLUSIONS
Induced PLTP deficiency in adult mice reduces plasma total cholesterol and triglycerides, prevents atherosclerosis progression, and promotes atherosclerosis regression.
Full Text
Conclusion: 6 weeks of brisk walking programme reduces plasma lipoprotein(a), percent body fat, waist circumference and resting blood pressure in overweight and obese females.
Full Text
We previously reported that dietary supplementation with cholic acid (CA), the primary 12α-hydroxylated (12αOH) bile acid (BA), reduces plasma adiponectin concentration in rats.
Full Text
In conclusion, in salt-sensitive hypertensive patients plasma MBG concentration correlates with 24-h diastolic blood pressure and dietary sodium restriction reduces plasma MBG levels.
Full Text
Citrate‐based anticoagulation reduces plasma potassium and free magnesium in patients undergoing peripheral stem cell collections.
Full Text
Of note, aHepGHRkd also reduces plasma IGF1 levels to >80% of GHR-intact controls (GHRfl/fl mice treated with AAV8-TBGp-Null), leading to a rise in GH, due to loss of IGF1 negative feedback to the pituitary/hypothalamus.
Full Text
It has been reported that EGCG reduces plasma nadolol bioavailability in normotensive models.
Full Text
Moreover, green tea enhances ovulation and reduces cyst formation in PCOS while improving generalised hyperalgesia, and reduces plasma corticosterone levels and uterine contractility in dysmenorrhea.
Full Text
Conclusion High-dose statin or combination of statins with ezetmibe reduces plasma ox-LDL in comparison low-to-moderate intensity statin therapy alone.
Full Text
AIMS
The selective sodium-glucose cotransporter 2 inhibitor empagliflozin increases urinary glucose, sodium excretion, and urinary volume, and reduces plasma glucose in type 2 diabetes mellitus (T2DM) patients.
Full Text
Further, Pcyox1 deficiency in Apoe-/- mice retards atheroprogression, is associated with decreased features of lesion vulnerability and lower levels of lipid peroxidation, reduces plasma lipid levels and inflammation.
Full Text
Six-month NAC treatment in EP patients reduces plasma sRAGE in association with increased prefrontal GABA, improvement of cognition and clinical symptoms, suggesting similar neuroprotective mechanisms.
Full Text
CONCLUSION
SM administration reduces plasma triglyceride levels through attenuation of triglyceride intestinal absorption and modulates cardiac lipotoxicity in the ischemic myocardium, likely contributing to improve ventricular remodeling.
Full Text
Conclusion Severe MR reduces plasma D-dimer levels to control levels reflecting the protective effect against thrombus formation and systemic embolization.
Full Text
Remarkably, GPR146 deficiency reduces plasma cholesterol levels substantially in both wild-type and LDL receptor (LDLR)-deficient mice.
Full Text
We validated the effect of Agpat5, showing in multiple mouse models that treatment with Agpat5 antisense oligonucleotide (ASO) reduces plasma insulin after high-fat feeding.
Full Text
Chronic energy insufficiency resulting from inadequate feed intake or increased nutrient demand reduces plasma leptin in ruminants.
Full Text
SSYX reduces plasma NT-proBNP levels, lending support for its therapeutic potential in HF management.
Full Text
Discontinuation of dietary red meat reduces plasma TMAO within 4 weeks.
Full Text
&NA; The therapy with proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors efficiently reduces plasma cholesterol levels, which has been recently associated with improvement in cardiovascular outcomes.
Full Text
Berberine (BBR) is a natural lipid lowering drug that reduces plasma LDL-cholesterol (LDL-C), total cholesterol (TC) and TG in hyperlipidemic patients and in mice by mechanisms involving upregulation of hepatic LDL receptor (LDLR).
Full Text
Conclusion: This meta-analysis has shown that curcuminoid therapy significantly reduces plasma triglycerides and increases HDL-C levels.
Full Text
Intravaginal administration in mice shows excellent NP retention for >6 h and markedly increases local AF levels, but reduces plasma and liver levels compared to oral treatment with a much higher dose.
Full Text
Depleting the endogenous BR content reduces plasma membrane localization of TTL3-GFP, while increasing BR content causes its plasma membrane relocalization, where it strengthens the association of BR signaling components.
Full Text
One such substance, miR-181, reduces plasma triglyceride levels in mice by targeting isocitrate dehydrogenase 1.
Full Text
We have previously shown that the Pro251 variant of perilipin‐2 reduces plasma triglycerides and may therefore be beneficial to reduce atherosclerosis development.
Full Text
CONCLUSIONS
Our results indicate that SG reduces plasma ET-1 levels, a possible mechanism for improved metabolic risk in these patients.
Full Text